Versantis Information

Versantis is a clinical-stage pharmaceutical company developing a new generation of orphan medicines to revolutionize the care of patients with liver and rare pediatric diseases. We address the unmet medical needs in emergency care. Our mission is to support acute decompensations of cirrhosis and to save infants born with rare genetic disorders.

Website	http://www.versantis.com
Revenue	$3 million
Employees	5 (2 on RocketReach)
Founded	2015
Phone	+41 44 633 06 72
Technologies	JavaScript , HTML , PHP +15 more (view full list)
Industry	Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Health Care, Hepatology, Retail, Health Diagnostics, Hyperammonemia, Pharmaceutical, Metabolic disease, Therapeutics, Liver diseases
Web Rank	8 Million
Keywords	Pediatric Diseases, Rare Diseases, Clinical Stage Pharmaceutical, Pharmaceutical Research, Drug Development, Emergency Care, Unmet Medical Needs, Hepatology, Clinical Trials, Innovative Medicines, Medical Innovation, Therapeutic Solutions, Health Care Solutions
Competitors	Alnylam Pharmaceuticals, Madrigal Pharmaceuticals, Intercept Pharmaceuticals, Terns Pharmaceuticals, Sientra, Inc., Foresight Ventures, Ivenix, Inc., Eiger BioPharmaceuticals, Galmed Pharmaceuticals Ltd., Hepion Pharmaceuticals +31 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies